BROOKS — Brooks Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Brooks Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	51.8	13.8	0.473	0.434	65.9
Net Total Accounts Receivable
Net Total Receivables	278	146	200	233	185
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	612	276	310	339	374
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,245	148	136	140	157
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,959	1,096	904	1,237	1,482
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	489	330	230	228	218
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	1,329	356	249	256	255
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	631	740	656	981	1,227
Total Liabilities & Shareholders' Equity	1,959	1,096	904	1,237	1,482
Total Common Shares Outstanding